TABLE 1.
Characteristic | Intervention
|
Control
|
||
---|---|---|---|---|
M | (SD) | M | (SD) | |
Age (years) | 60.6 | (16.6) | 62.2 | (18.2) |
Catheter (months) | 73.1 | (87.4) | 71.9 | (83.8) |
Catheter size (Fr) | 18.4 | (3.3) | 18.7 | (3.2) |
|
|
|||
n | (%) | n | (%) | |
|
||||
Gender (male) | 53 | (52.4) | 50 | (50.0) |
Catheter type | ||||
Urethral | 57 | (56.4) | 55 | (54.5) |
Suprapubic | 43 | (42.6) | 46 | (45.5) |
Both | 1 | (0.0) | 0 | (0.0) |
Catheter balloon size | ||||
5–10 ml | 64 | (63.4) | 60 | (59.4) |
30 ml | 11 | (10.9) | 18 | (17.8) |
Other | 1 | (1.0) | 1 | (1.0) |
Unknown/no answer | 25 | (24.8) | 22 | (21.8) |
Note. There were 101 participants in each group. None of the characteristics was significantly associated with treatment group assignment. Median duration of catheter use in the intervention group was 42 months; control group median was 37 months. Additional detailed information about the sample is available in Wilde, McDonald et al. (2013).